Skip Navigation
Skip to contents

JLC : Journal of Liver Cancer

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
1 "Jung Wan Choe"
Filter
Filter
Article category
Publication year
Case Report
A case report of a patient presented with skin ulcer after treatment of lenvatinib
Serin Cha, Dong Woo Kim, Jung Wan Choe, Tae Hyung Kim, Seung Young Kim, Jong Jin Hyun, Sung Woo Jung, Ja Seol Koo, Young Kul Jung, Hyung Joon Yim
J Liver Cancer. 2021;21(2):194-198.   Published online September 30, 2021
DOI: https://doi.org/10.17998/jlc.2021.09.20
  • 9,674 Views
  • 123 Downloads
  • 8 Citations
AbstractAbstract PDF
A 60-year-old man diagnosed with unresectable hepatocellular carcinoma (HCC) presented to the hospital with pain in the perineal region. He had been taking lenvatinib every day for 2 months after he was diagnosed with HCC with metastases to the lymph node, small bowel mesentery, and retroperitoneal space. Enhanced abdominal computed tomography revealed mild elevation in intensity in the perineal subcutaneous tissue with subcutaneous emphysema. The patient was diagnosed with Common Terminology Criteria for Adverse Events grade 3, skin ulceration of stage IV with full-thickness skin loss and tissue necrosis in the muscular layer. The patient was taken off the medication with prescription of antibiotics, and after 3 weeks, the skin has fully recovered. This is the first report of an HCC patient who presented with a skin ulceration of stage IV after lenvatinib treatment. We recommend stopping the medication immediately and changing to alternative treatments with appropriate supportive care.

Citations

Citations to this article as recorded by  
  • Drug-induced skin ulcer: real-world pharmacovigilance analysis based on the FDA adverse event reporting system
    Qiubai Jin, Jiufei Fang, Feihong Ren, Jiaqi Li, Shuanglin Zhou, Ping Song
    Expert Opinion on Drug Safety.2026; 25(5): 863.     CrossRef
  • Clinical Management of Adverse Effects Associated with Domestic Lenvatinib in Hepatocellular Carcinoma Patients under Volume-Based Procurement Policy
    凯鑫 靳
    Asian Case Reports in Emergency Medicine.2026; 14(02): 282.     CrossRef
  • Case Report: Lenvatinib-induced lichenoid drug reaction mimicking disseminated zoster in a patient with metastatic hepatocellular carcinoma
    Maria Kaufman, Rodrigo Garcia-Santisteban, Crystal Choi, Rohit Merugu, Samuel Kareff
    Frontiers in Oncology.2026;[Epub]     CrossRef
  • Lenvatinib-Associated Vaginal Necrosis and Rectovaginal Fistula After Brachytherapy
    Keiichiro Baba, Taisuke Sumiya, Takashi Saito, Motohiro Murakami, Hideyuki Sakurai
    Cureus.2025;[Epub]     CrossRef
  • Hospital-Based Observational Study of Mucocutaneous Adverse Reactions of Tyrosine Kinase Inhibitors
    Sona C. Gowda, Tonita Mariola Noronha, Vijith Shetty
    Indian Journal of Medical and Paediatric Oncology.2025;[Epub]     CrossRef
  • Roles of clinical application of lenvatinib and its resistance mechanism in advanced hepatocellular carcinoma (Review)
    Ganghui Ye
    American Journal of Cancer Research.2024; 14(9): 4113.     CrossRef
  • Multiple lenvatinib‐associated skin ulcers: A case report and literature review
    Soo Hyun Jeon, Woo Jin Lee, Chong Hyun Won, Sung Eun Chang, Mi Woo Lee, Joon Min Jung
    Australasian Journal of Dermatology.2023;[Epub]     CrossRef
  • Tyrosine Kinase Inhibitors Induced Scrotal Ulcerations
    Abhipsa Samal, Nibedita Dixit, Bikash R. Kar, Liza Mohapatra
    Indian Journal of Dermatology.2023; 68(2): 235.     CrossRef
Close layer

JLC : Journal of Liver Cancer
TOP